UPDATE : Sunday, January 26, 2020
상단여백
KIRAMS develops indicator to predict radiotherapy effectiveness by Shim Hyun-tai 2020-01-23 09:23
'Reimbursement for Repatha to expand treatment options for ASCVD patients' by Lee Han-soo 2020-01-22 15:14
Sales of antidiabetic SGLT-2 inhibitors grew 40% in 2019 by Kim Yun-mi 2020-01-22 15:10
South Korea raises alert level of coronavirus by Shim Hyun-tai 2020-01-21 18:30
Celltrion Group to build biopharmaceutical plant in China by Lee Han-soo 2020-01-21 18:00
라인
HanAll remains positive of eye treatment’s efficacy despite initial failure by Lee Han-soo 2020-01-21 15:12
SK Biopharma’s US partner gets EMA nod for sleepiness treatment by Lee Han-soo 2020-01-21 14:22
GC MS partners with Rootee Health for new testing biz by Lee Han-soo 2020-01-21 14:21
Some Merck Korea workers commute from provinces to Seoul every day by Kim Yun-mi 2020-01-21 14:21
Daewoong’s Jeuveau sold ₩40 billion in US in 8 months by Jeong Sae-im 2020-01-21 11:43
라인
Long-term survivors of prostate cancer maintain high QOL after surgery by Shim Hyun-tai 2020-01-20 18:07
Genomictree’s US offshoot draws $10 million in investment by Lee Han-soo 2020-01-20 18:06
Roche Diagnostic launches non-small-cell lung carcinoma diagnostic kit by Lee Han-soo 2020-01-20 17:25
‘Government should control next-generation sequencing data’ by Kim Yun-mi 2020-01-20 15:47
CoImmune acquires Formula Pharmaceuticals by Lee Han-soo 2020-01-20 15:45
라인
Pfizer’s spinoff of generics unit causes disputes with trade union by Kim Yun-mi 2020-01-20 15:44
Gangnam Severance Hospital installs Da Vinci Xi robot surgery device by Lee Han-soo 2020-01-20 14:05
T&R Biofab to export medical devices to Malaysia by Lee Han-soo 2020-01-20 14:05
Korea’s botulinum toxin exports hit record high in 2019 by Jeong Sae-im 2020-01-20 11:38
Takeda’s Kynteles expands indication for ulcerative colitis, Crohn’s disease by Kim Yun-mi 2020-01-17 17:30
여백
여백
여백
Back to Top